Wuhan, China

Xianbo Liu


 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Xianbo Liu

Introduction

Xianbo Liu is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of eight patents to his name, Liu's work has the potential to impact the treatment of neurological diseases and cancer.

Latest Patents

Liu's latest patents include innovative compounds that serve as nuclear transport modulators. These compounds are designed to inhibit nuclear transporters, such as the exportin-1 transporter, and can be utilized in treating neurological diseases and cancer. Another notable patent involves compounds that act as neurokinin-1 receptor antagonists. These compounds are believed to offer therapeutic benefits for conditions such as chemotherapy-induced nausea and vomiting (CINV) and post-operative nausea and vomiting (PONV).

Career Highlights

Throughout his career, Xianbo Liu has worked with various companies, including XWPharma Ltd. and XW Laboratories Inc. His expertise in pharmaceutical development has positioned him as a key figure in the industry, contributing to advancements in medical treatments.

Collaborations

Liu has collaborated with notable colleagues, including Jia-Ning Xiang and Zude Qi. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Xianbo Liu's innovative work in the pharmaceutical field demonstrates his commitment to advancing medical science. His patents reflect a dedication to improving treatment options for patients suffering from serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…